-
2
-
-
0024602608
-
A phase 1 a clinical trial of Lym-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies
-
(1989)
Hematol Oncol
, vol.7
, pp. 155-166
-
-
Hu, E.1
Epstein, A.L.2
Naeve, G.S.3
Gill, L.4
Martin, S.5
Sherrod, A.6
Nichols, P.7
Chen, D.8
Mazumder, A.9
Levine, A.M.10
-
3
-
-
7844233336
-
131I-Lym-1 antibody
-
(1998)
Cancer Biother Radiopharm
, vol.13
, pp. 239-254
-
-
DeNardo, G.L.1
DeNardo, S.J.2
Lamborn, K.R.3
Goldstein, D.S.4
Levy, N.B.5
Lewis, J.P.6
O'Grady, L.F.7
Raventos, A.8
Kroger, L.A.9
Macey, D.J.10
-
6
-
-
14444270630
-
67Cu-2IT-BAT-Lym-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: A pilot study
-
(1998)
Anticancer Research
, vol.18
, pp. 2779-2788
-
-
DeNardo, G.L.1
DeNardo, S.J.2
Kukis, D.L.3
O'Donnell, R.T.4
Shen, S.5
Goldstein, D.S.6
Kroger, L.A.7
Salako, Q.8
DeNardo, D.A.9
Mirick, G.R.10
-
8
-
-
0001443043
-
Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and patients with Iymphoma
-
(1991)
Antibody Immunoconj Radiophar
, vol.4
, pp. 777-785
-
-
DeNardo, G.L.1
DeNardo, S.J.2
Meares, C.F.3
Kukis, D.L.4
Diril, H.5
McCall, M.J.6
Adams, G.P.7
Mausner, L.F.8
Moody, D.C.9
Deshpande, S.V.10
-
10
-
-
0033375231
-
67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma
-
(1999)
J Nucl Med
, vol.40
, pp. 2014-2020
-
-
O'Donnell, R.T.1
DeNardo, G.L.2
Kukis, D.L.3
Lamborn, K.R.4
Shen, S.5
Yuan, A.6
Goldstein, D.S.7
Carr, C.E.8
Mirick, G.R.9
DeNardo, S.J.10
-
11
-
-
0031759838
-
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue
-
(1998)
3 Clin Oncol
, vol.16
, pp. 3270-3278
-
-
Liu, S.Y.1
Eary, J.F.2
Petersdorf, S.H.3
Martin, P.J.4
Maloney, D.G.5
Appelbaum, F.R.6
Matthews, D.C.7
Bush, S.A.8
Durack, L.D.9
Fisher, D.R.10
-
12
-
-
9044254117
-
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
-
(1996)
Clin Cancer Res
, vol.2
, pp. 457-470
-
-
Knox, S.J.1
Goris, M.L.2
Trisler, K.3
Negrin, R.4
Davis, T.5
Liles, T.-M.6
Grillo-Lopez, A.J.7
Chinn, P.8
Varns, C.9
Ning, S.-C.10
-
13
-
-
0032910019
-
90Y-based radioimmunotherapy
-
(1999)
Med Phys
, vol.26
, pp. 799-809
-
-
Clarke, K.G.1
Odom-Maryon, T.L.2
Williams, L.E.3
Liu, A.4
Lopatin, G.5
Chou, J.6
Farino, G.M.7
Raubitschek, A.A.8
Wong, J.Y.C.9
-
14
-
-
8944248819
-
Iodine-131-anti-B1 radioimmunotherapy for B-cell Iymphoma
-
(1996)
J Clin Oncol
, vol.14
, pp. 1974-1981
-
-
Kaminski, M.S.1
Zasadny, K.R.2
Francis, I.R.3
Fenner, M.C.4
Ross, C.W.5
Milik, A.W.6
Estes, J.7
Tuck, M.8
Regan, D.9
Fisher, S.10
-
15
-
-
0031828752
-
Iodine-131 antibody for B-cell Iymphoma: An update on the Michigan Phase I Experience
-
(1998)
J Nucl Med
, vol.39
-
-
Wahl, R.L.1
Zasadny, K.R.2
MacFarlane, D.3
Francis, I.R.4
Ross, C.W.5
Estes, J.6
Fisher, S.7
Regan, D.8
Kroll, S.9
Kaminski, M.S.10
-
16
-
-
0032748607
-
90Y-labeled anti-CD 20 monoclonal antibody
-
(1999)
Clin Cancer Res
, vol.5
-
-
Wiseman, G.A.1
White, C.A.2
Witzig, T.E.3
Gordon, L.L.4
Emmanouilides, C.5
Raubitschek, A.6
Janakiraman, N.7
Gutheil, J.8
Schilder, R.J.9
Spies, S.10
-
18
-
-
0032697615
-
90Y-labeled humanized LL2 anti-CD22 monoclonal antibody (MAb) in patients with relapsed/refractory non-Hodgkin's Iymphoma (NHL)
-
(1999)
Clin Cancer Res
, vol.5
-
-
Juweid, M.E.1
Stadtmauer, E.2
Sharkey, R.M.3
Hajjar, G.4
Suleiman, S.5
Luger, S.6
Swayne, L.C.7
Alavi, A.8
Goldenberg, D.M.9
-
21
-
-
85078982526
-
Radiochemistry of therapeutic radionuclides
-
Cancer Therapy with Radiolabeled Antibodies. (Goldenberg, DM, ed). Boca Raton, FL, CRC Press
-
(1995)
, pp. 47-61
-
-
Griffiths, G.L.1
-
22
-
-
0023137637
-
Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human-B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential
-
(1987)
Cancer Res
, vol.47
, pp. 830-840
-
-
Epstein, A.L.1
Marder, R.J.2
Winter, J.N.3
Stathopoulos, E.4
Chen, F.M.5
Parker, J.W.6
Taylo, C.R.7
-
24
-
-
0032588605
-
67Cu-2-IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma
-
(1999)
J Nucl Med
, vol.40
, pp. 302-310
-
-
DeNardo, S.J.1
DeNardo, G.L.2
Kukis, D.L.3
Shen, S.4
Kroger, L.A.5
DeNardo, D.A.6
Goldstein, D.S.7
Mirick, G.R.8
Salako, Q.9
Mausner, L.F.10
-
26
-
-
0030816178
-
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: Results of a phase I clinical trial
-
(1997)
J Nucl Med
, vol.38
, pp. 1180-1185
-
-
DeNardo, S.J.1
Kramer, E.L.2
O'Donnell, R.T.3
Richman, C.M.4
Salako, Q.A.5
Shen, S.6
Noz, M.7
Glenn, S.D.8
Ceriani, R.L.9
DeNardo, G.L.10
-
29
-
-
0030012729
-
Dosimetric evaluation of Copper-64 in Copper-67-2IT-BAT-Lym- 1 for radioimmunotherapy
-
(1996)
J Nucl Med
, vol.37
, pp. 146-150
-
-
Shen, S.1
DeNardo, G.L.2
DeNardo, S.J.3
Salako, Q.4
Morris, G.5
Banks, D.6
Yuan, A.7
DeNardo, D.A.8
-
31
-
-
0030885111
-
Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources
-
(1997)
J Nucl Med
, vol.38
, pp. 1374-1378
-
-
Lim, S.-M.1
DeNardo, G.L.2
DeNardo, D.A.3
Shen, S.4
Yuan, A.5
O'Donnell, R.T.6
DeNardo, S.J.7
-
32
-
-
0003562305
-
Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation, part 2
-
New York, Society of Nuclear Medicine
-
(1970)
MIRD Pamphlet No. 6
-
-
Dillman, L.T.1
-
35
-
-
84987480164
-
Treatment of B cell malignancies with I-131 Lym-1 monoclonal antibodies
-
(1988)
Int J Cancer
, vol.3
, Issue.SUPPL.
, pp. 96-101
-
-
DeNardo, S.J.1
DeNardo, G.L.2
O'Grady, L.F.3
Hu, E.4
Sytsma, V.M.5
Mills, S.L.6
Levy, N.B.7
Macey, D.J.8
Miller, C.H.9
Epstein, A.L.10
-
36
-
-
0032589763
-
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma
-
(1999)
Clin Cancer Res
, vol.10
, pp. 3330-3336
-
-
O'Donnell, R.T.1
DeNardo, G.L.2
Kukis, D.L.3
Lamborn, K.R.4
Shen, S.5
Yuan, A.6
Goldstein, D.S.7
Mirick, G.R.8
DeNardo, S.J.9
-
37
-
-
0031759837
-
131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma
-
(1998)
J Clin Oncol
, vol.16
, pp. 3246-3256
-
-
DeNardo, G.L.1
DeNardo, S.J.2
Goldstein, D.S.3
Kroger, L.A.4
Lamborn, K.R.5
Levy, N.B.6
McGahan, J.P.7
Salako, Q.A.8
Shen, S.9
Lewis, J.P.10
-
38
-
-
0030952417
-
Yttrium-90/Indium-111-DOTA-peptide-Chimeric L6: Pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
-
(1997)
Anticancer Research
, vol.17
, pp. 1735-1744
-
-
DeNardo, S.J.1
Richman, C.M.2
Goldstein, D.S.3
Shen, S.4
Salako, Q.A.5
Kukis, D.L.6
Meares, C.F.7
Yuan, A.8
Welborn, J.L.9
DeNardo, G.L.10
-
39
-
-
0028098048
-
Human anti-mouse antibody suppression with cyclosporin A
-
(1994)
Cancer
, vol.73
, pp. 1093-1097
-
-
Weiden, P.L.1
Wolf, S.B.2
Breitz, H.B.3
Appelbaum, J.W.4
Seiler, C.A.5
Mallett, R.6
Bjorn, M.J.7
Su, F.M.8
Fer, M.F.9
Salk, D.10
|